Staff eye doses in a large medical centre in Saudi Arabia: are they meeting the new ICRP recommendations?

A 5-y retrospective analysis of the cardiology staff eye doses was performed on 34 staff from different categories (cardiologists, nurses and technologists) at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh, Saudi Arabia. KFSHRC is a tertiary medical centre with 800-bed capacity having more than 5000 cardiac catheterisation procedures performed annually. The aim of the study is to derive staff doses to the lens of the eyes using the personal dose equivalent Hp(0.

Radioactive waste handling and disposal at King Faisal Specialist Hospital and Research Centre.

King Faisal Specialist Hospital & Research Centre (KFSHRC) is the largest specialized medical center in Saudi Arabia. It performs highly specialized diagnostic imaging procedures with the use of various radionuclides required by sophisticated dual imaging systems. As a leading institution in cancer research, KFSHRC uses both long-lived and short-lived radionuclides.

Deriving staff and public doses in a PET/CT facility from measured radiation levels using thermoluminescent dosimetry.

The introduction of PET/CT at King Faisal Specialist Hospital and Research Centre for whole body and brain imaging has become favourable for diagnosis of cancer. There is no data available on the PET/CT dose to staff and members of the public for different activities of (18)F [fluorodeoxyglucose (FDG)] and for longer patient holding time. The study aims to determine and evaluate staff and public doses by using thermoluminescent dosemeters monthly readings for a 7-month deployment period and by using direct measurements of dose rates at 30 cm and 1 m distances from the patients after injection.

Variation in radiation doses in paediatric cardiac catheterisation procedures.

Paediatric cardiac catheterisation involves diagnostic and therapeutic procedures that range from simple to complex and can subject paediatric patients to varying radiation doses. The study aims to determine the variation in entrance doses in patients in terms of dose-area product (DAP) values and to investigate the methods for optimising radiation protection. A total of 190 paediatric patients belonging to age groups 0, 1, 5 and 10 y who underwent diagnostic and six selected therapeutic procedures at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia were included in the study.

Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.

Patients administered with a therapeutic dose of I for thyroid cancer treatment are potential sources of unacceptably high radiation exposure to other individuals, particularly the patient's immediate family members. Generally, patients are hospitalized until such time that the retained radioactivity in the body or the measured dose rate at 1 m from the patient's body surface fall to within acceptable levels. Patient release criteria are set to ensure that no individual shall be liable to receive exposures above the regulatory dose limit for the public or dose constraints for the patient's relatives or caregivers.